Generalized Anxiety Disorder (GAD) Overview

Generalized anxiety disorder (GAD) is aPersistent, excessive worry and tensionA mental illness characterized by uncontrollable anxiety about daily life events (such as work, health, or relationships), accompanied bysomatic symptoms(eg fatigue, muscle tension, sleep disturbance). Its core features arewidespread anxiety(covering multiple areas) andChronic(lasts for more than 6 months). The diagnosis needs to exclude other mental or physical illnesses, and treatment includespsychotherapy(such as cognitive behavioral therapy) andpharmacological intervention(such as antidepressants). The primary and secondary content structure is as follows: 1) Definition and characteristics; 2) Symptom manifestations; 3) Causes and risk factors; 4) Diagnosis and treatment; 5) Prognosis and self-management.

Symptoms and daily impact

Patients with GAD often exhibitDual psychological and physical symptoms. Psychologically, they worry excessively about trivial matters, accompanied by difficulty concentrating, irritability, or "catastrophic thinking"; physically, they may experience palpitations, sweating, gastrointestinal discomfort, or headaches. These symptoms can significantly interfere with social interaction, work ability, and even lead to avoidance behaviors (such as refusing to go out). Unlike ordinary anxiety, GAD worry isuncontrollable, and lacks specific trigger points. For example, a patient may associate a child being 10 minutes late with a serious car accident and remain in a state of panic for several hours.

Analysis of causes and risk factors

The cause of GAD is not yet fully understood, but research suggests that it is related toBiological, psychological and social factorsrelated to joint effects. biologically,genetic predisposition(Family history increases risk 5-fold) andneurotransmitter imbalance(such as serotonin, gamma-aminobutyric acid abnormalities) are key; psychological aspects, childhood trauma or long-term stress may change the brain's sensitivity to threats; social factors include economic hardship or interpersonal conflict. Risk groups include women (the prevalence is twice as high as men), adults aged 20-40, and perfectionists.

Diagnostic criteria and treatment options

According toDiagnostic and Statistical Manual of Mental Disorders (DSM-5), GAD needs to meet: 1) excessive anxiety lasting for more than 6 months; 2) accompanied by at least 3 physical symptoms; 3) excluding physical diseases such as hyperthyroidism. Treatment of choiceCognitive behavioral therapy (CBT), relieve anxiety by modifying negative thinking patterns; drugs are commonly usedSSRIs antidepressants(such as sertraline) orBenzodiazepine short-term relievers(Such as alprazolam, need to prevent dependence). Some patients can try mindfulness training or regular exercise to help improve their symptoms.

Prognosis and self-management recommendations

Although GAD is a chronic disease, itAbout 50% of patients can achieve significant relief through standard treatment. Those with poorer prognosis often suffer from depression or do not adhere to treatment. Self-management includes: 1) journaling about anxiety triggers; 2) practicing abdominal breathing or progressive muscle relaxation; and 3) limiting caffeine intake. Need to be vigilantOver-self-diagnosis——Transient anxiety is a normal reaction, and medical attention is only required when symptoms persist and affect function. Some health products (such as products containing L-theanine) may assist relief, but there is a lack of clinical evidence, so you need to choose with caution.

Quote sources:1. American Psychiatric Association (APA) "Diagnostic and Statistical Manual of Mental Disorders (DSM-5)" 2. World Health Organization (WHO) "International Classification of Diseases (ICD-11)" 3. Harvard Medical School "Guidelines for the Diagnosis and Treatment of Anxiety Disorders" (2022) 4. Product information reference: Public data from the official websites of Pfizer Pharmaceuticals and Wyeth Pharmaceuticals